Management of Men with Prostate-specific Antigen Failure After Prostate Radiotherapy: The Case Against Early Androgen Deprivation

Publication date: Available online 3 January 2018 Source:European Urology Author(s): Douglas Brand, Chris ParkerTeaser In men with prostate-specific antigen failure after radical radiotherapy, androgen deprivation therapy should be delayed until the site of recurrence is known to allow consideration of curative treatment options, to delay androgen deprivation therapy-related morbidity, and to enable earlier access to abiraterone and docetaxel.
Source: European Urology - Category: Urology & Nephrology Source Type: research